Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Oct 18, 2013
Trading Halt
Oct 10, 2013
Appendix 3B
Oct 09, 2013
Response to ASX Price Query
Oct 09, 2013
Investor presentation
Oct 01, 2013
Neuren data presented at Fragile X Foundation meeting
Sep 26, 2013
Appendix 3B
Sep 19, 2013
Change of Director's Interest Notice
Sep 11, 2013
Appendix 3B
Sep 09, 2013
Neuren opens new IND for NNZ-2566 in Fragile X Syndrome
Sep 04, 2013
Final Director's Interest Notice
Previous
1
2
3
4
5
6
7
8
Next
